The perioperative preservation of functionality and quality of life plays an increasingly important role in older physically limited and frail patients undergoing cardiac surgery. Hereby, impairments of the skeletal muscle system integrity often contributes to a reduced physical performance. Early identification of these high-risk patients could help to initiate appropriate preventive and therapeutic measures. Volatile organic compounds (VOC) represent a non-invasive and real-time measurable approach for recording physiological and pathophysiological processes. Isoprene (2-methyl-1,3-butadiene) is one of the most abundantly exhaled VOCs and has recently been shown to originate from skeletal muscle metabolism. However, the prognostic value of isoprene as a volatile biomarker for skeletal muscle integrity, physical performance and functional outcome in patients undergoing cardiac surgery has not been evaluated before.
This is a single center prospective observational study evaluating exhaled isoprene as a perioperative volatile biomarker of skeletal muscle integrity, physical performance and functional outcome in cardiosurgical patients. All study participants will be assessed by comprehensive clinical examinations, laboratory testing, breath analysis and skeletal muscle ultrasound before, during as well as five and thirty days after surgery. Clinical assessments will be performed using established clinical scores and scales (e.g. the Short Physical Performance Battery and the Fried Frailty Index). Laboratory testing comprises a broad panel of blood-based biomarkers of skeletal muscle integrity and metabolism. The investigators hypothesize that: * perioperative exhaled isoprene levels correlate with postoperative measures of physical performance, functional outcome and morbidity * perioperative exhaled isoprene levels differ between patients with and without physical frailty * perioperative exhaled isoprene levels correlate with sonographic and laboratory parameters of skeletal muscle integrity
Study Type
OBSERVATIONAL
Enrollment
66
Assessment of physical performance using established clinical tests and scoring systems
Sampling of exhaled breath and using Proton-transfer-reaction time-of-flight mass spectrometry (PTR-TOF) for VOC quantification.
Quantitative and qualitative assessment of different limb skeletal muscles using non-invasive ultrasound.
Blood sampling and assessment of different blood-based biomarkers of muscle integrity using Enzyme-linked Immunosorbent Assay (ELISA) and Electrochemiluminescence Immunoassay (ECLIA)
Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, Rostock University Medical Center
Rostock, Mecklenburg-Vorpommern, Germany
RECRUITINGShort Physical Performance Battery
Assessment of patient's physical performance using the Short Physical Performance Battery (SPPB, Score, scales 0-12), whereby a higher SPPB corresponds to a better physical performance.
Time frame: day 5 after surgery
Cumulated Ambulation Score
Assessment of functional patient outcome using the Cumulated Ambulation Score (CAS, Score, scales 0-6), whereby a higher CAS corresponds to a better functional outcome.
Time frame: days 5 and 30 after surgery
Morbidity
Assessment of the cumulative number of postoperative complications after surgery.
Time frame: day 30 after surgery
Isoprene concentration in patients with and without frailty
Comparison of exhaled isoprene levels (concentrations, part per billion volume - ppbV) measured by PTR-TOF between patients with and without physical frailty.
Time frame: day 5 after surgery
Medical Research Council Sum Score
Assessment of general muscle strength of study participants using the Medical Research Council Sum Score (MRCSS, Score, scales 0-60), whereby a higher MRCSS corresponds to a higher muscle strength.
Time frame: day 5 after surgery
Muscle thickness
Assessment of muscle thickness (mm) using muscle ultrasound in eight different limb skeletal muscles.
Time frame: day 5 after surgery
Concentrations of blood-based biomarkers
Assessment of blood-based biomarker concentrations (pmol/l) of skeletal muscle integrity and metabolism.
Time frame: day 5 after surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.